U
AZN icon

UBS’s AstraZeneca AZN Stock Holding History

UBS’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$5.94M Sell
83,200
-31,300
-27% -$2.29M ﹤0.01% 1866
2014
Q2 		$8.51M Buy
114,500
+63,600
+125% +$4.6M 0.01% 1497
2014
Q1 		$3.3M Buy
50,900
+35,700
+235% +$2.31M ﹤0.01% 2256
2013
Q4 		$902K Sell
15,200
-38,300
-72% -$2.08M ﹤0.01% 3659
2013
Q3 		$2.78M Buy
53,500
+30,200
+130% +$1.52M ﹤0.01% 2269
2013
Q2 		$1.1M Buy
+23,300
New +$1.19M ﹤0.01% 3220

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

UBS's AZN Position: Q3 2014 in Review

UBS reduced its AstraZeneca (AZN) stake by 2.7% in Q3 2014, selling an estimated $3.49M and leaving 1,725,695 shares worth $123M. The position accounts for 0.09% of the portfolio, ranked #231.

UBS first reported a position in AZN in Q2 2013 and has held it in 6 quarters since. The position peaked at $295M in Q3 2013. 401 funds tracked by Wall St. Rank hold AZN as of Q3 2014.

  • UBS held 1,725,695 shares of AstraZeneca worth $123M as of Q3 2014.
  • UBS sold 47,642 AstraZeneca shares in Q3 2014, an estimated $3.49M.
  • AstraZeneca made up 0.09% of UBS's portfolio in Q3 2014, its #231 holding.
  • UBS first reported a position in AstraZeneca in Q2 2013 and has held it in 6 quarters since.
  • UBS's AstraZeneca position peaked at $295M in Q3 2013.
  • 401 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.